Myo-Inositol

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 216 Experts worldwide ranked by ideXlab platform

Barry V. L. Potter - One of the best experts on this subject based on the ideXlab platform.

  • Synthesis of d- and l-Myo-Inositol 2,4,5-trisphosphate and trisphosphorothioate: structural analogues of d-Myo-Inositol 1,4,5-trisphosphate
    Carbohydrate Research, 2002
    Co-Authors: Stephen J. Mills, Barry V. L. Potter
    Abstract:

    Abstract The preparation of d - and l -Myo-Inositol 2,4,5-trisphosphate is described, together with the phosphorothioate counterparts. The known chiral diols d - and l -1,4-di-O-benzyl-5,6-bis-O-p-methoxybenzyl-Myo-Inositol were regioselectively protected at the 3-position using a benzyl group via a 2,3-O-stannylene acetal. Removal of the p-methoxybenzyl groups of each enantiomer gave d - and l -1,3,6-tri-O-benzyl-Myo-Inositol. Phosphitylation with bis(benzyloxy)diisoproplyaminophosphine and 1H-tetrazole gave the trisphosphite intermediate for each enantiomer. Oxidation with 3-chloroperoxybenzoic acid gave the fully protected d - and l -Myo-Inositol 2,4,5-trisphosphates. Sulphoxidation of the d - and l -2,4,5-trisphosphite intermediates gave the fully protected d - and l -Myo-Inositol 2,4,5-trisphosphorothioate compounds. The fully protected trisphosphates were deblocked using hydrogenolysis and the phosphorothioates were deprotected using sodium in liquid ammonia. The individual compounds were then purified using ion exchange chromatography to afford pure d - and l -Myo-Inositol 2,4,5-trisphosphates together with the corresponding phosphorothioates.

  • Synthesis of the enantiomers of 6-deoxy-Myo-Inositol 1,3,4,5-tetrakisphosphate, structural analogues of Myo-Inositol 1,3,4,5-tetrakisphosphate.
    Chemistry: A European Journal, 2001
    Co-Authors: Graeme Horne, Barry V. L. Potter
    Abstract:

    : D-Myo-Inositol 1,3,4,5-tetrakisphosphate [Ins(1,3,4,5)P4] is produced rapidly from the established second messenger D-Myo-Inositol 1,4,5-trisphosphate [Ins(1,4,5)P4] in stimulated cells. Despite extensive investigations, in particular concerning its potential role in mediating cellular Ca2+ influx, no exact cellular function has been described for this inositol phosphate; however, binding sites have been identified in a number of tissues and it has been shown to act synergistically with Ins(1,4,5)P3. To assist in the elucidation of the mechanism of action and structural requirements within the Ins(1,3,4,5)P4 moiety that are necessary for recognition and activation of the receptor, structural analogues of this tetrakisphosphate are required. Routes for the synthesis of racemic 6-deoxy-Myo-Inositol 1,3,4,5-tetrakisphosphate [6-deoxy-DL-Ins(1,3,4,5)P4] and the chiral antipodes D- and L-6-deoxy-Myo-Inositol 1,3,4,5-tetrakisphosphate are described here. The racemic tetrakisphosphate was synthesised from DL-1,2-O-isopropylidene-Myo-Inositol in eight steps. Deoxygenation at C-6 was achieved following the Barton-McCombie procedure. Both chiral tetrakisphosphates were synthesised through resolution of racemic cis-diol 6-deoxy-1,4,5-tri-O-p-methoxybenzyl-Myo-Inositol with the chiral auxiliary (S)-(+)-O-acetylmandelic acid. Absolute configuration was confirmed by synthesis of the known D-6-deoxy-Myo-Inositol. Both D-6-deoxy-Ins(1,3,4,5)P4 and its enantiomer will be useful tools to unravel the enigmatic role of Ins(1,3,4,5)P4 in the polyphosphoinositide pathway of signal transduction.

  • Investigation of the inframolecular acid-base properties of D-Myo-Inositol 1,3,4,5-tetrakisphosphate and DL-Myo-Inositol 1,2,4,5-tetrakisphosphate
    Chemical Communications, 1997
    Co-Authors: Philippe Guédat, Barry V. L. Potter, Andrew M. Riley, Gilbert Schlewer, Elisabeth Krempp, Bernard Spiess
    Abstract:

    The protonation processes of the individual phosphate groups in two regioisomeric inositol polyphosphates, D-Myo-Inositol 1,3,4,5-tetrakisphosphate and DL-Myo-Inositol 1,2,4,5-tetrakisphosphate, have been investigated by 31 P NMR titration experiments; the results are compared to those from D-Myo-Inositol 1,4,5-trisphosphate.

  • Myo-Inositol 1,4,6-trisphosphorothioate and Myo-Inositol 1,3,4-trisphosphorothioate: New synthetic Ca2+-mobilising partial agonists at the inositol 1,4,5-trisphosphate receptor
    Bioorganic & Medicinal Chemistry Letters, 1995
    Co-Authors: Stephen J. Mills, Andrew M. Riley, C T Murphy, Anthony J. Bullock, John Westwick, Barry V. L. Potter
    Abstract:

    Abstract Syntheses of myo -inositol 1,4,6-trisphosphorothioate and 1,3,4-trisphosphorothioate from myo -inositol are described; these trisphosphorothioates, derived from structure-activity considerations of myo -inositol 1,3,4,6-tetrakisphosphate, are low intrinsic activity partial agonists at the platelet Ins(1,4,5)P 3 receptor.

  • Unambiguous Total Synthesis of the Enantiomers of Myo-Inositol 1,3,4-Trisphosphate: 1L-Myo-Inositol 1,3,4-Trisphosphate Mobilizes Intracellular Ca2+ in Limulus Photoreceptors
    Journal of Medicinal Chemistry, 1994
    Co-Authors: Andrew M. Riley, Richard J. Payne, Barry V. L. Potter
    Abstract:

    : Syntheses of the enantiomers of Myo-Inositol 1,3,4-trisphosphate are described. 1,4-Di-O-allyl-Myo-Inositol was regioselectively p-methoxybenzylated at the 3-position to give 1,4-di-O-allyl-3-O-(p-methoxybenzyl)-Myo-Inositol followed by benzylation of the remaining free hydroxyl groups to give the key intermediate 1,4-di-O-allyl-2,5,6-tri-O-benzyl-3-O-(p-methoxybenzyl)-Myo-Inositol. Removal of the p-methoxybenzyl and allyl groups gave 2,4,5-tri-O-benzyl-Myo-Inositol which was phosphitylated with bis(benzyloxy)(diisopropylamino)phosphine to give the fully protected trisphosphite triester. Oxidation using tert-butyl hydroperoxide gave 2,5,6-tri-O-benzyl-1,3,4-tris(dibenzylphospho)-Myo-Inositol, and deprotection using sodium in liquid ammonia gave racemic Myo-Inositol 1,3,4-trisphosphate. Deprotection of the key intermediate 1,4-di-O-allyl-2,5,6-tri-O-benzyl-3-O-(p-methoxybenzyl)-Myo-Inositol by isomerization of allyl groups followed by mild acid hydrolysis gave 2,4,5-tri-O-benzyl-1-O-(p-methoxybenzyl)-Myo-Inositol, which was converted to the diastereoisomeric (bis-(-)-camphanates. The diastereoisomers were separated by column chromatography and the camphanates and the p-methoxybenzyl group removed by saponification and acid hydrolysis, respectively, for each diastereoisomer to give the enantiomers of 2,4,5-tri-O-benzyl-Myo-Inositol. The absolute configurations of the latter were established by conversion of 1L-2,5,6-tri-O-benzyl-3-O-(p-methoxybenyl)-Myo-Inositol to the known 1L-1,2,4,5,6-penta-O-benzyl-Myo-Inositol. Phosphorylation and deblocking gave the D- and L-enantiomers of Myo-Inositol 1,3,4-trisphosphate. Biological evaluation in Limulus photoreceptors showed that 1L-Myo-Inositol 1,3,4-trisphosphate was much more active than the D-enantiomer, producing repetitive bursts of depolarization due to mobilization of intracellular calcium.

Mohan M. Bhadbhade - One of the best experts on this subject based on the ideXlab platform.

Mysore S. Shashidhar - One of the best experts on this subject based on the ideXlab platform.

Kana M. Sureshan - One of the best experts on this subject based on the ideXlab platform.

Rajesh G. Gonnade - One of the best experts on this subject based on the ideXlab platform.